Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Diabetes: Management and Pharmacotherapy

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...

Type I Diabetes I: Introduction

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...

Diabetes Mellitus: Overview and Type I Subtype

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...

Insulin: Dosing Regimen and Adverse Effects

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...

Type I Diabetes II: Pathophysiology

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...

Assessing Blood pressure using a doppler ultrasound

Assessing Blood pressure using a doppler ultrasound

To obtain accurate blood pressure measurements in clinical settings, especially when traditional methods are insufficient, healthcare professionals utilize the Doppler ultrasound technique. This method uses high-frequency sound waves to detect blood flow within the arteries, which is crucial for patients with conditions that complicate circulatory system assessment.
Pre-Procedural Guidelines for Doppler Ultrasound Blood Pressure Assessment:
Preparation of Equipment:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Reversible alterations of brain acetate metabolism associated with alcohol consumption.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology·2026

Same author

When the system fails: Barriers to type 1 diabetes medication access and the emergent role of social media support.

Diabetic medicine : a journal of the British Diabetic Association·2026

Same author

The <i>Real</i> "Real World": Overcoming Practical Barriers and Disparities in Diabetes Technology.

Diabetes technology & therapeutics·2026

Same author

Testing Multiple Delivery Methods of the Virtual Exercise Games for Youth with T1D Peer Intervention: Protocol Development and Feasibility.

Hormone research in paediatrics·2026

Same author

Practical Considerations and Implementation of Automated Insulin Delivery Systems.

Journal of diabetes science and technology·2025

Same author

Early Stages of Automated Insulin Delivery.

Journal of diabetes science and technology·2025

Search research articles

Related Experiment Video

Updated: Jul 7, 2026

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid

Published on: April 7, 2023

Sensor-augmented pump therapy in type 1 diabetes.

Stuart A Weinzimer¹, William V Tamborlane

¹Department of Pediatrics, Center for Clinical Investigation, Yale University School of Medicine, New Haven, Connecticut 06520-8064, USA. stuart.weinzimer@yale.edu

Current Opinion in Endocrinology, Diabetes, and Obesity

|March 5, 2008

Summary

Continuous glucose monitoring (CGM) sensors improve type 1 diabetes management by providing glucose trends. Sensor-augmented pump therapy is a significant advancement, likely to become standard care.

More Related Videos

Human Pseudoislet System for Synchronous Assessment of Fluorescent Biosensor Dynamics and Hormone Secretory Profiles

Human Pseudoislet System for Synchronous Assessment of Fluorescent Biosensor Dynamics and Hormone Secretory Profiles

Published on: November 3, 2023

Related Experiment Videos

Last Updated: Jul 7, 2026

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid

Published on: April 7, 2023

Human Pseudoislet System for Synchronous Assessment of Fluorescent Biosensor Dynamics and Hormone Secretory Profiles

Human Pseudoislet System for Synchronous Assessment of Fluorescent Biosensor Dynamics and Hormone Secretory Profiles

Published on: November 3, 2023

Area of Science:

Endocrinology
Biomedical Engineering
Diabetes Technology

Background:

Technological advancements are transforming type 1 diabetes management.
Continuous glucose monitoring (CGM) is increasingly used alongside traditional blood glucose monitoring.
CGM integrated with continuous subcutaneous insulin infusion (CSII) systems paves the way for artificial pancreas development.

Purpose of the Study:

To review emerging glucose sensor technologies for diabetes management.
To evaluate the accuracy and effectiveness of continuous glucose sensors based on current literature.

Main Methods:

Literature review of studies evaluating continuous glucose sensors.
Analysis of sensor accuracy compared to traditional blood glucose monitoring.
Assessment of clinical outcomes and patient-reported satisfaction.

Main Results:

Continuous glucose sensors offer trend data not available with conventional testing, despite lower accuracy than traditional methods.
Short-term studies show CGM reduces HbA1c and time spent in hypoglycemia and hyperglycemia.
Patient acceptance is linked to data quality, comfort, and usability.

Conclusions:

Sensor-augmented insulin pump therapy marks a major improvement in type 1 diabetes care and is expected to become standard.
Future research should prioritize enhancing sensor accuracy and developing intuitive algorithms for patient self-management.